Home » Newsletters » BioWorld Science

BioWorld Science

May 28, 2003

View Archived Issues

Heterocyclic antiobesity agents in early development at Bayer

New quinolone-based antibacterial agents prepared and tested at Sato

Kyoto Pharmaceutical and Sankyo present novel carbapenem antibiotics

Boehringer Ingelheim patent covers cathepsin inhibitors for autoimmune diseases and other uses

Takeda scientists identify novel MCH receptor antagonists

New 5-HT1B/5-HT1D antagonists and their use claimed by AstraZeneca

Five related series of COX-2 inhibitors reported by Pfizer in recent patents

Use of donepezil in vascular dementia and Alzheimer's disease discussed at AGS meeting

Additional benefits reported for eplerenone combined with other drugs in hypertension

Recent clinical findings for olmesartan medoxomil reported at ASH meeting

LY-293111 improves the antitumor efficacy of gemcitabine in a murine pancreatic cancer model

Seretide approved in E.U.

Peninsula and Shionogi reach doripenem licensing agreement

Orphan drug status sought for CTCE-9908 in Europe

Nippon Shinyaku acquires Japanese rights to acamprosate

Mitsubishi files for European approval of argatroban, establishes German subsidiary

Oxytrol submission accepted for review in Canada

Japanese sNDA submitted for Cleactor for acute pulmonary embolism

NIH grant supports development of E-Matrix for diabetic foot ulcers

Endocyte begins phase I trial of FolateImmune for cancer

Restructuring at Northwest Biotherapeutics

BioTie Therapies updates progress

Inhibitor of calcium-activated chloride channel evaluated in mouse model of mucus hypersecretion

Neuroprotective antioxidant effective in rodent models of Parkinson's disease

Potential of potent and selective adenosine A1 antagonist in the oral treatment of asthma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...